The future looks a little brighter for Advanced Magnetics. The company reported a 3Q net profit of $703,981, or 11¢ per share, as compared with a net loss of $398,756, or 6¢ per share, for the same period in 2000. Working capital remains strong
The future looks a little brighter for Advanced Magnetics. The company reported a 3Q net profit of $703,981, or 11¢ per share, as compared with a net loss of $398,756, or 6¢ per share, for the same period in 2000. Working capital remains strong at approximately $24 million. Advanced Magnetics is a biopharmaceutical company that develops imaging agents to aid in the diagnosis of cancer and cardiovascular disease as well as therapeutic iron compounds for treating anemia.
Computed Tomography Study Assesses Model for Predicting Recurrence of Non-Small Cell Lung Cancer
January 31st 2025A predictive model for non-small cell lung cancer (NSCLC) recurrence, based on clinical parameters and CT findings, demonstrated an 85.2 percent AUC and 83.3 percent sensitivity rate, according to external validation testing in a new study.